Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 106,176 | 21,505 | -282,368 | -116,937 | -81,708 |
| Depreciation Amortization | 3,564 | 5,580 | 11,970 | 12,656 | 11,260 |
| Accounts receivable | 4,091 | -68,893 | 1,207 | -17,303 | -10,336 |
| Other Working Capital | -941 | -99,993 | 1,512 | -25,389 | -5,519 |
| Other Operating Activity | 55,946 | 152,526 | 196,797 | 46,220 | 60,369 |
| Operating Cash Flow | $168,836 | $10,725 | $-70,882 | $-100,753 | $-25,934 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,842 | -6,921 | 1,212 | -2,668 | -3,981 |
| Purchase Of Investment | N/A | N/A | -3,241 | -191,354 | -311,116 |
| Sale Of Investment | N/A | N/A | 99,165 | 346,890 | 237,423 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -100,000 |
| Other Investing Activity | 0 | -4,223 | -8,270 | -1,408 | -100,000 |
| Investing Cash Flow | $-1,842 | $-11,144 | $88,866 | $151,460 | $-177,674 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 403,174 | N/A | 146,250 | N/A |
| Debt Repayment | N/A | -383,747 | -1,824 | -3,234 | -1,903 |
| Common Stock Issued | 18,546 | 13,595 | 32,061 | 26,370 | 24,841 |
| Common Stock Repurchased | N/A | -25,159 | N/A | N/A | N/A |
| Other Financing Activity | 0 | -9,048 | -165 | -149,551 | -27,114 |
| Financing Cash Flow | $18,546 | $-1,185 | $30,072 | $19,835 | $-4,176 |
| Beginning Cash Position | 179,244 | 180,848 | 132,792 | 62,250 | 270,034 |
| End Cash Position | 364,784 | 179,244 | 180,848 | 132,792 | 62,250 |
| Net Cash Flow | $185,540 | $-1,604 | $48,056 | $70,542 | $-207,784 |
| Free Cash Flow | |||||
| Operating Cash Flow | 168,836 | 10,725 | -70,882 | -100,753 | -25,934 |
| Capital Expenditure | -1,842 | -7,189 | -351 | -2,803 | -4,206 |
| Free Cash Flow | 166,994 | 3,536 | -71,233 | -103,556 | -30,140 |